Study design, baseline patient characteristics and intervention in a cross-cultural framework: results from the ADORE study
Ulrich W. Preuss(SymbioPharm (Germany)), Rob Rodrigues Pereira(GGD Rotterdam-Rijnmond), Bruno Falissard(Inserm), Gísli Baldursson(National University Hospital of Iceland), David Coghill(The University of Melbourne), Laurens Vlasveld(Reinier de Graaf Hospital), M. J. Varas Lorenzo(Eli Lilly (United Kingdom)), Stephen J. Ralston
Cited by 54
Related Papers
Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder
|Nature Genetics|2018|2.3k
Genomic Relationships, Novel Loci, and Pleiotropic Mechanisms across Eight Psychiatric Disorders
|Cell|2019|1.5k
The World Federation of ADHD International Consensus Statement: 208 Evidence-based conclusions about the disorder
|Neuroscience & Biobehavioral Reviews|2021|1.4k